Novavax begins participant crossover in two COVID-19 vaccine trials

PUBLISHED: Mon, 05 Apr 2021 20:15:14 GMT

April 5 (Reuters) – Novavax Inc on Monday said it had begun to crossover patients in its ongoing COVID-19 vaccine trials in South Africa and the UK to ensure participants who previously received placebo also receive active vaccine. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Anil D’Silva)

(c) Copyright Thomson Reuters 2021. Click For Restrictions –

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.